KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.09%.

  • Emergent BioSolutions' Return on Capital Employed rose 2000.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 2000.0%. This contributed to the annual value of 0.08% for FY2024, which is 3200.0% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Return on Capital Employed of 0.09% as of Q3 2025, which was up 2000.0% from 0.08% recorded in Q2 2025.
  • Emergent BioSolutions' Return on Capital Employed's 5-year high stood at 0.21% during Q1 2021, with a 5-year trough of 0.6% in Q4 2023.
  • Over the past 5 years, Emergent BioSolutions' median Return on Capital Employed value was 0.08% (recorded in 2025), while the average stood at 0.1%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by -6100bps in 2023, then skyrocketed by 5200bps in 2024.
  • Emergent BioSolutions' Return on Capital Employed (Quarter) stood at 0.13% in 2021, then crashed by -170bps to 0.09% in 2022, then plummeted by -538bps to 0.6% in 2023, then surged by 86bps to 0.09% in 2024, then skyrocketed by 206bps to 0.09% in 2025.
  • Its Return on Capital Employed stands at 0.09% for Q3 2025, versus 0.08% for Q2 2025 and 0.08% for Q1 2025.